To address this issue, we first performed comparative expression study of these factors on tissue sections from Chinese patients with benign melanocytic nevus, primary dermal and metastatic melanomas using antibodies specific for SOX9, SOX10, and NEDD9 [17, 31]. This evidence concerns the gene SOX10 and metastatic melanoma.